'do not do' recommendations in hemophilia.

CONCLUSIONS: The information mentioned previously can be useful in the management of hemophilia, from different levels of care. As far as we know, this is the first initiative of this type in hemophilia.
PMID: 32133968 [PubMed - as supplied by publisher]

Source: Cardiovascular and Hematological Disorders Drug Targets - March 7, 2020 Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research